PMA P830063S019

Device
Prismaflex TPE2000 Set
Applicant
Vantive US Healthcare, LLC
PMA number
P830063
Supplement
S019
Product code
MDP
Decision date
2021-06-24
Generic name
Separator for therapeutic purposes, membrane automated blood cell/plasma
Approval order statement
Transfer the production of some components of the Prismaflex TPE2000 set to alternate Baxter locations.

Current openFDA PMA Record#

Device
Prismaflex TPE2000 Set
Applicant
Vantive US Healthcare, LLC
PMA number
P830063
Supplement
S019
Product code
MDP
Generic name
Separator for therapeutic purposes, membrane automated blood cell/plasma
Decision date
2021-06-24
Decision code
OK30
Date received
2021-05-26
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Transfer the production of some components of the Prismaflex TPE2000 set to alternate Baxter locations.